Kristina Glick
Nurse Practitioner · Kokomo, INNPI 1154647634
Payments from drug & device makers
Across 120 payments — averaging $15.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$636
- Dexcom, Inc.$216
- Lilly USA, LLC$216
- Novo Nordisk$208
- GSK$115
- Otsuka America Pharmaceutical, Inc.$114
- plus $405 from 13 others
What the payments were for
- Food & beverage$1,910100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 45 | $636 |
| Dexcom, Inc. | 14 | $216 |
| Lilly USA, LLC | 13 | $216 |
| Novo Nordisk | 15 | $208 |
| GSK | 5 | $115 |
| Otsuka America Pharmaceutical, Inc. | 6 | $114 |
| Pfizer | 3 | $76 |
| Gilead | 3 | $59 |
| Supernus Pharmaceuticals, Inc. | 2 | $55 |
| Exact Sciences | 3 | $49 |
| Lundbeck LLC | 3 | $48 |
| Ironshore Pharmaceuticals Inc. | 1 | $20 |
| Corcept Therapeutics | 1 | $18 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Boston Scientific | 1 | $15 |
| Cranial Technologies, Inc | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
| Organon | 1 | $9 |
How this compares
$1,910 in reported general payments places this provider in the 80th percentile of 2,724 nurse practitioner providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 262 | $268,571 |
| MounjaroTirzepatide | 105 | $109,758 |
| RybelsusSemaglutide | 34 | $41,303 |
| RexultiBrexpiprazole | 23 | $36,917 |
| JardianceEmpagliflozin | 51 | $34,266 |
| VraylarCariprazine Hcl | 19 | $26,658 |
| Tresiba Flextouch U-200Insulin Degludec | 25 | $21,148 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 22 | $20,625 |
| Tresiba Flextouch U-100Insulin Degludec | 18 | $16,348 |
| EliquisApixaban | 20 | $11,702 |
| JanuviaSitagliptin Phosphate | 11 | $11,637 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 25 | $10,579 |
| TradjentaLinagliptin | 14 | $9,240 |
| SymbicortBudesonide/Formoterol Fumarate | 28 | $8,813 |
| Spiriva HandihalerTiotropium Bromide | 11 | $8,753 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $208 | $309,874296 claims |
| Lilly USA, LLCMounjaro | $216 | $109,758105 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $114 | $36,91723 claims |
| AbbVieVraylar | $636 | $26,65819 claims |
| PfizerEliquis | $76 | $11,70220 claims |
| GSKAnoro Ellipta | $115 | $10,57925 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,724 nurse practitioner providers in Indiana.
Other nurse practitioner in Kokomo
- Kristi OrbaughIndianapolis$1.3M
- Kimberly EadsPlainfield$302K
- Sean GoddardFort Wayne$180K
- Kacy RogersIndianapolis$77K
- Kristine TaylorFort Wayne$69K
- Brittany SavageIndianapolis$51K
- Monica HaugerTrafalgar$47K
- Rhonda HettingerClarksville$38K
- Jennifer MaahsIndianapolis$36K
- Amber MillerLawrenceburg$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.